![]() |
|
|||
|
Acomplia Information Resource
What is Acomplia? Acomplia is the brand name of a new prescription weight loss drug for dieters, Rimonabant, that has recently (June 28th, 2006) been approved for use by patients in the UK. Who is Acomplia suitable for? It is designed as a slimming aid for obese patients or overweight patients with other risk factors such as type 2 diabetes or dyslipidaemia - see BMI for the definitions of what constitutes overweight or obese. In particular, the drug reduces the risk of heart disease and type 2 diabetes. It may also help people to stop smoking, although it has not yet been licensed for this purpose. Acomplia tips - Acomplia also reduces the desire for nicotine, but is not yet licensed as an aid to stopping smoking. - Acomplia is licensed within the European Union, but has yet to be approved by the FDA in the US. - The Acomplia capsule is red and yellow, and the recommended dose is one 20mg tablet once a day, before breakfast. - Acomplia is manufactured by the pharmaceutical company Sanofi Aventis. Its generic name is Rimonabant. |
![]() |
| Thread Tools | |
| Display Modes | |
|
|